As state lawmakers debate ways to make insulin more affordable, U.S. Senator Tina Smith introduced a bill at the federal level to force drug companies to push prices down.
“It sets up an emergency supply of insulin and most importantly it says to the big drug companies we want you to pay a fee in order to make this emergency supply available to people.”
The average price for a vial of short-acting insulin increased 585-percent over the past 14 years:
“We want to crack down on these monopolistic practices that are contributing to the high price of insulin. Especially for people that don’t have insurance or are underinsured — they have poor insurance.”